The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–291 of 291
Ehlers, S., Hölscher, C., Scheu, S., Tertilt, C., Hehlgans, T., Suwinski, J., Endres, R., & Pfeffer, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5210 · Cited by 151
Pettit, A. R., Walsh, N. C., Manning, C., Goldring, S. R., & Gravallese, E. M. (2006) · Rheumatology · doi:10.1093/rheumatology/kel045 · Cited by 151 · cited 2×
“…concentrations of RANKL in serum, synovial fluid or synovial tissue; however, reports differ as to whether OPG expression is increased or decreased in patients with RA (Feuerherm et al., 2001; Kotake et al., 2001; Ziolkowska et al., 2002; Catrina et al., 2006; Petit et al., 2006, Vis et al., 2006).”
BackgroundModulation of CD28 expression with anti–tumor necrosis factor α therapy in rheumatoid arthritis
Bryl, E., Vallejo, A. N., Matteson, E. L., Witkowski, J. M., Weyand, C. M., & Goronzy, J. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21353 · Cited by 150
Butler, D., Malfait, A., Mason, L. J., Warden, P., Kollias, G. A., Maini, R. N., Feldmann, M., & Brennan, F. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2867 · Cited by 149
Revisiting the Role of Tumor Necrosis Factor α and the Response to Surgical Injury and Inflammation
Ksontini, R., MacKay, S. L., & Moldawer, L. L. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.5.558 · Cited by 146
Koenders, M. I., Joosten, L. A. B., & van den Berg, W. B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058529 · Cited by 145
Alexopoulou, L., Pasparakis, M., & Kollias, G. A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271018 · Cited by 141
Terslev, L., Torp-Pedersen, S., Qvistgaard, E., Kristoffersen, H., Røgind, H., Danneskiold-Samsøe, B., & Bliddal, H. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.2.178 · Cited by 139
Lee, C., Lee, E. Y., Chung, S. M., Mun, S. H., Yoo, B., & Moon, H. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20637 · Cited by 137 · cited 1×
“In addition, osteoclast formation and activity in vitro were directly inhibited by infliximab and, to a lesser degree, by methotrexate, sulfasalazine and IL-4 in cocultures of human mononuclear cells and RA fibroblast-like synoviocytes (Lee et al., 2004).”
BackgroundRecognition of immunoglobulins by Fcγ receptors
Radaev, S., & Sun, P. D. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00036-6 · Cited by 136
Harashima, S., Horiuchi, T., Hatta, N., Morita, C., Higuchi, M., Sawabe, T., Tsukamoto, H., Tahira, T., Hayashi, K., Fujita, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.130 · Cited by 131
Tutuncu, Z. N., Kavanaugh, A., Zvaifler, N. J., Corr, M., Deutsch, R., & Boyle, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21266 · Cited by 130
Goedkoop, A. Y., Kraan, M. C., Picavet, D. I., de Rie, M. A., Teunissen, M. B. M., Bos, J. D., & Tak, P. P. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1182 · Cited by 128
Self-citationModulating TNF-α signaling with natural products
Paul, A. T., Gohil, V. M., & Bhutani, K. K. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.002 · Cited by 125
Zhou, H. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004273321 · Cited by 125
Atzeni, F., Sarzi‐Puttini, P., Acqua, D. D., de Portu, S., Cecchini, G., Cruini, C., Carrabba, M., & Meroni, P. L. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1851 · Cited by 122
A Role for the Lymphotoxin/LIGHT Axis in the Pathogenesis of Murine Collagen-Induced Arthritis
Fava, R. A., Notidis, E., Hunt, J., Szanya, V., Ratcliffe, N. R., Ngam-ek, A., de Fougerolles, A. R., Sprague, A., & Browning, J. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.115 · Cited by 121
Organogenesis of peripheral lymphoid organs
Nishikawa, S., Honda, K., Vieira, P., & Yoshida, H. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00063.x · Cited by 119
Isomäki, P., Panesar, M., Annenkov, A. E., Clark, J. M., Foxwell, B. M. J., Chernajovsky, Y., & Cope, A. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5495 · Cited by 119
Chen, H.-A., Lin, K., Chen, C.-H., Liao, H., Wang, H.-P., Chang, H.-N., Tsai, C., & Chou, C. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038851 · Cited by 117
Expression of the lymphotoxin β receptor on follicular stromal cells in human lymphoid tissues
Murphy, M., Walter, B. N., Pike-Nobile, L., Fanger, N. A., Guyre, P. M., Browning, J. L., Ware, C. F., & Epstein, L. B. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400374 · Cited by 116
Kim, E. Y., & Teh, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4500 · Cited by 116
Hultgren, O., Eugster, H., Sedgwick, J. D., Körner, H., & Tarkowski, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5937 · Cited by 116
Markham, T., Mullan, R. H., Golden‐Mason, L., Rogers, S. C. F., Bresnihan, B., FitzGerald, O., Fearon, U., & Veale, D. J. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.01.038 · Cited by 115
Barrera, P., Joosten, L. A. B., den Broeder, A. A., van de Putte, L. B. A., van Riel, P. L. C. M., & van den Berg, W. B. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.7.660 · Cited by 115
TNF pathophysiology in murine models of chronic inflammation and autoimmunity
Kollias, G. A. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.01.002 · Cited by 114
Medvedev, A. E., Espevik, T., Ranges, G. E., & Sundan, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9778 · Cited by 113
Rheumatoid arthritis and malignant lymphomas
Baecklund, E., Askling, J., Rosenquist, R., Ekbom, A., & Klareskog, L. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00014 · Cited by 113
Self-citationHow does infliximab work in rheumatoid arthritis?
Maini, R. N., & Feldmann, M. (2002) · Arthritis Research · doi:10.1186/ar549 · Cited by 112
Catrina, A. I., af Klint, E., Ernestam, S., Catrina, S., Makrygiannakis, D., Botusan, I. R., Klareskog, L., & Ulfgren, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21528 · Cited by 112
Self-citationO' Gradaigh, D., Ireland, D., Bord, S., & Compston, J. E. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.008458 · Cited by 111
D’Alessio, A., Al‐Lamki, R. S., Bradley, J. R., & Pober, J. S. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62346-2 · Cited by 110
Goedkoop, A. Y., Kraan, M. C., Teunissen, M. B. M., Picavet, D. I., de Rie, M. A., Bos, J. D., & Tak, P. P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018085 · Cited by 109
Self-citationB cells in rheumatoid arthritis: from hypothesis to the clinic
Keystone, E. C. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh617 · Cited by 108
Hultgren, O., Eugster, H., Sedgwick, J. D., Körner, H., & Tarkowski, A. (1998) · PubMed · Cited by 106
Cohen, P. S., Nakshatri, H., Dennis, J., Caragine, T. A., Bianchi, M., Cerami, A., & Tracey, K. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3967 · Cited by 95
Differentiating the efficacy of the tumor necrosis factor inhibitors
Haraoui, B. P. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.01.003 · Cited by 95
IL-4 Inhibits Bone-Resorbing Activity of Mature Osteoclasts by Affecting NF-κB and Ca2+ Signaling
Mangashetti, L. S., Khapli, S. M., & Wani, M. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.917 · Cited by 95
McDevitt, H. O., Munson, S. H., Ettinger, R., & Wu, A. J. (2002) · Arthritis Research · doi:10.1186/ar570 · Cited by 95
Synovial macrophage-osteoclast differentiation in inflammatory arthritis
Danks, L., Sabokbar, A., Gundle, R., & Athanasou, N. A. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.10.916 · Cited by 95
Anti–tumor necrosis factor therapies
Taylor, P. C. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200105000-00003 · Cited by 93
Safety of biologic therapies--an update.
Keystone, E. C. (2005) · PubMed · Cited by 92
Kirchner, S., Holler, E., Haffner, S., Andreesen, R., & Eißner, G. (2004) · Cytokine · doi:10.1016/j.cyto.2004.06.008 · Cited by 91
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies
Kruithof, E., Rycke, L. D., Roth, J., Mielants, H., den Bosch, F. E. V., Keyser, F. D., VEYS, E. M., & Baeten, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21426 · Cited by 90
Berg, L., Lampa, J., Rogberg, S., van Vollenhoven, R., & Klareskog, L. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.2.133 · Cited by 88
Self-citationCytokine production in synovial tissue of mice with collagen-induced arthritis (CIA)
MÜSSENER, Å., Litton, M. J., Lindroos, E., & Klareskog, L. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.3181214.x · Cited by 85
Self-citationDiscovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies
Feldmann, M., & Maini, R. N. (2002) · Joint Bone Spine · doi:10.1016/s1297-319x(01)00335-9 · Cited by 84
Maini, R. N., Taylor, P. C., Paleolog, E. M., Charles, P. J., Ballara, S., Brennan, F. M., & Feldmann, M. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i56 · Cited by 84
Sasso, E. H., Barber, C. V., Nardella, F. A., Yount, W. J., & Mannik, M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.3098 · Cited by 83
Self-citationEngwerda, C. R., Ato, M., Stäger, S., Alexander, C. E., Stanley, A. C., & Kaye, P. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63262-2 · Cited by 82
Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis
A. J. Feuerherm, M. B., Børset, M., & Seid, C. (2001) · Scandinavian Journal of Rheumatology · doi:10.1080/030097401316909585 · Cited by 82
Acute and “chronic” phase reaction—a mother of disease
Bengmark, S. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.07.016 · Cited by 74
New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease.
Sandborn, W. J. (2005) · PubMed · Cited by 73
Shen, C., Assche, G. V., Rutgeerts, P. J., & Ceuppens, J. L. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194185.69800.07 · Cited by 71
Wu, Q., Sun, Y., Wang, J., Lin, X., Wang, Y., Pegg, L. E., Fütterer, A., Pfeffer, K., & Fu, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1684 · Cited by 68
Immune Function in Patients with Rheumatoid Arthritis Treated with Etanercept
Moreland, L. W., Bucy, R. P., Weinblatt, M. E., Mohler, K. M., Spencer-Green, G., & Chatham, W. W. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5183 · Cited by 67
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis
Barrera, P., Oyen, W. J. G., Boerman, O. C., & van Riel, P. L. C. M. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.825 · Cited by 67
Ito, D., Back, T. C., Shakhov, A. N., et al. (1999) · PubMed · Cited by 65
Lange, F., Bajtner, E., Rintisch, C., Nandakumar, K. S., Sack, U., & Holmdahl, R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.026120 · Cited by 65
Gordon, K. B., Bonish, B. K., Patel, T. C., Leonardi, C., & Nickoloff, B. J. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06816.x · Cited by 60
Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients
Malaviya, R., Sun, Y., Tan, J. K., Wang, A., Magliocco, M. A., Yao, M., Krueger, J. G., & Gottlieb, A. B. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.004 · Cited by 58
Alexopoulou, L., Pasparakis, M., & Kollias, G. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.745 · Cited by 58
Cordiali‐Fei, P., Trento, E., D’Agosto, G., Bordignon, V., Mussi, A., Ardigò, M., Mastroianni, A., Vento, A., Solivetti, F. M., Berardesca, E., et al. (2006) · Journal of Autoimmune Diseases · doi:10.1186/1740-2557-3-5 · Cited by 56
Straub, R. H., Härle, P., Sarzi‐Puttini, P., & Cutolo, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21946 · Cited by 55
Biologic Agents for the Treatment of Juvenile Rheumatoid Arthritis: Current Status
Carrasco, R., Smith, J. A., & Lovell, D. J. (2004) · Pediatric Drugs · doi:10.2165/00148581-200406030-00001 · Cited by 54
B cells in rheumatoid synovitis.
Weyand, C. M., Seyler, T. M., & Goronzy, J. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1737 · Cited by 54
Thalidomide-derived immunomodulatory drugs as therapeutic agents
Galustian, C., Labarthe, M., Marriott, J. B., & Dalgleish, A. G. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.12.1963 · Cited by 51
Bieber, J. D., & Kavanaugh, A. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.01.003 · Cited by 51
Multiple Deficiencies Underlie NK Cell Inactivity in Lymphotoxin-α Gene-Targeted Mice
Smyth, M. J., Johnstone, R. W., Cretney, E., Haynes, N. M., Sedgwick, J. D., Korner, H., Poulton, L. D., & Baxter, A. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1350 · Cited by 51
Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis
Krüger‐Krasagakis, S., Galanopoulos, V. K., Giannikaki, L., Stefanidou, M. P., & Tosca, A. D. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07078.x · Cited by 49
Kollias, G. A., Kontoyiannis, D. L., Douni, E. K., & Kassiotis, G. (2001) · KARGER eBooks · doi:10.1159/000060546 · Cited by 47
Klareskog, L., & McDevitt, H. O. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00033-3 · Cited by 47
Self-citationLiepinsh, D. J., Grivennikov, S. I., Klarmann, K. D., Lagarkova, M. A., Drutskaya, M. S., Lockett, S., Tessarollo, L., McAuliffe, M., Keller, J. R., Kuprash, D. V., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01751-05 · Cited by 45
Weir, N., Athwal, D., Brown, D. T., Foulkes, R., Kollias, G. A., Nesbitt, A. M., Popplewell, A., Spitali, M., & Stephens, S. (2006) · Therapy · doi:10.2217/14750708.3.4.535 · Cited by 45
Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice.
Smyth, M. J., Johnstone, R. W., Cretney, E., Haynes, N. M., Sedgwick, J. D., Körner, H., Poulton, L. D., & Baxter, A. G. (1999) · PubMed · Cited by 44
ALSALAMEH, WINTER, AL‐WARD, Wendler, Kalden, & KINNE (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00458.x · Cited by 44
van Lent, P. L. E. M., Blom, A. B., Grevers, L., Sloetjes, A. W., & van den Berg, W. B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057471 · Cited by 41
Williams-Abbott, L., Walter, B. N., Cheung, T. C., Goh, C. R., Porter, A. G., & Ware, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19451 · Cited by 37
Kubota, A., Hasegawa, K., Suguro, T., & Koshihara, Y. (2004) · PubMed · Cited by 37
Caffieri, S., Lisa, F. D., Bolesani, F., Facco, M., Semenzato, G., Dall’Acqua, F., & Canton, M. (2007) · Blood · doi:10.1182/blood-2006-08-037192 · Cited by 35
Edwards, C. K., Bendele, A. M., Reznikov, L. L., Fantuzzi, G., Chlipala, E. S., Li, L., Moldawer, L. L., Mountz, J. D., Li, Y. Y., & Dinarello, C. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22077 · Cited by 33
Rheumatoid arthritis: inflammation and bone loss
Schett, G. A. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-005-0244-7 · Cited by 33
Fossati, G., & Nesbitt, A. M. (2005) · The American Journal of Gastroenterology · doi:10.14309/00000434-200509001-00806 · Cited by 33
Crotti, T. N., Ahern, M. J., Lange, K. M., Weedon, H., Coleman, M. J., Roberts-Thomson, P. J., Haynes, D. R., & Smith, M. (2003) · PubMed · Cited by 24
Effects of infliximab treatment on rheumatoid synovial tissue.
Tak, P. P. (2005) · PubMed · Cited by 24
Self-citationWee, S., Pascual, M. A., Eason, J. D., et al. (1997) · Transplantation · doi:10.1097/00007890-199702270-00015 · Cited by 20
Müeller, R. B., Skapenko, A., Grünke, M., Wendler, J., Stuhlmüller, B., Kalden, J. R., & Schulze‐Koops, H. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20863 · Cited by 18
Aggarwal, A., Panda, S., & Misra, R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012617 · Cited by 17
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Cytokines in Inflammatory Disease
Kany, S., Vollrath, J. T., & Relja, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236008 · Cited by 1,971
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,694
Metadata
- Authors
- Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 117
- Issue
- 2
- Pages
- 244-279
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1997106678
- Cited by
- 1,628
- References
- 291
- FWCI
- 55.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.